comparemela.com

Latest Breaking News On - Pharma intermediates - Page 1 : comparemela.com

Aarti Drugs listed as top pick of the week by Axis Securities – 4 key reasons

The brokerage has a ‘buy’ recommendation on the stock with a target price of ₹528, indicating an upside of 10 percent from its current market price of ₹480.30.

United statesAarti groupPharma intermediatesAarti drugsNorth americaLatin americaTarapur greenfield capexStock marketsAarti drugs stockAarti drugs share priceAarti drugs outlookAxis securities on aarti drugsAxis pick of the weekPick of the weekStock pickAxis securities

Infinium Pharmachem Ltd Reports Net Profit of Rs 6 13 crore in H1FY23, growth of 22 7 per cent Y-o-Y

Infinium Pharmachem Ltd Reports Net Profit of Rs 6 13 crore in H1FY23, growth of 22 7 per cent Y-o-Y
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.

United kingdomSun pharmaInfinium pharmachem ltdSyngene internationalManufacturing servicesDr reddy labContract researchPharma intermediatesBefore taxSpecialty chemicalSanand gujaratFine chemicalSai life

Paragon Fine IPO: Check GMP Today, Subscription, Price, Lot Size

Paragon Fine IPO: The initial public offering allotment will take place on November 1 and the shares are likely to be listed on the NSE SME on November 7

Paragon fineSpeciality chemicalsPharma intermediatesCosmetics intermediatesPigment intermediatesDye intermediatesViramgam district

Infinium Pharmachem Ltd approves 1:1 Bonus Issue

Infinium Pharmachem Ltd approves 1:1 Bonus Issue
bruneinews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bruneinews.net Daily Mail and Mail on Sunday newspapers.

United kingdomSun pharmaSanjaykumar patelDr reddy labManufacturing servicesSyngene internationalContract researchInfinium pharmachem ltdPharma intermediatesSpecialty chemicalManaging directorSanand gujaratFine chemicalSai life

Aarti Drugs shares zoom 19% to hit one-year high after strong Q1 FY24 results Details here

Aarti Drugs share price: On technical setup, the stock was last seen trading higher than the 5-day, 20-, 50-, 100- and 200-day moving averages. The counter's 14-day relative strength index (RSI) came at 83.71. A level below 30 is defined as oversold while a value above 70 is considered overbought. The company's stock has a price-to-earnings (P/E) ratio of 28.48 against a price-to-book (P/B) value of 4.24.

Adhish patilSaykha capexAarti group of industriesMaharashtra industrial development corporationRd division at tarapurPinnacle life science pvt ltdAarti drugs ltdGujarat saykha capexTarapur capexDrugs ltdAarti groupActive pharmaceutical ingredientsPharma intermediatesSpeciality chemicalsPinnacle life science pvtAarti drugs

vimarsana © 2020. All Rights Reserved.